Zobrazeno 1 - 10
of 576
pro vyhledávání: '"MORELLI MP"'
Autor:
Yousef M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Yousef A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Chowdhury S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Fanaeian MM; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Knafl M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston., Peterson J; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Zeineddine M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Alfaro K; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Zeineddine F; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Goldstein D; Syntropy Technologies LLC, Cambridge, Massachusetts., Hornstein N; Department of General Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Dasari A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Huey R; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Johnson B; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Higbie V; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Bent A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Kee B; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lee M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Morelli MP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Morris VK; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Halperin D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Overman MJ; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Parseghian C; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Vilar E; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston., Wolff R; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Raghav KP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., White MG; Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston., Uppal A; Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston., Sun R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston., Wang W; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston., Kopetz S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Willis J; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Shen JP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Nov 01; Vol. 10 (11), pp. 1519-1529.
Autor:
Cole CB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Morelli MP; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fantini M; Precision Biologics, Inc, Bethesda, MD, USA. massimo.fantini@precision-biologics.com., Miettinen M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fetsch P; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Peer C; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yin T; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Houston N; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McCoy A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lipkowitz S; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zimmer A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pavelova M; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Villanueva EN; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Trewhitt K; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Solarz BB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fergusson M; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mavroukakis SA; Precision Biologics, Inc, Bethesda, MD, USA., Zaki A; Precision Biologics, Inc, Bethesda, MD, USA., Tsang KY; Precision Biologics, Inc, Bethesda, MD, USA., Arlen PM; Precision Biologics, Inc, Bethesda, MD, USA., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. annunzic@mail.nih.gov.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 29; Vol. 42 (1), pp. 76. Date of Electronic Publication: 2023 Mar 29.
Autor:
Simmons K; Department of Hematology/Oncology, Baylor College of Medicine, Houston, Texas., Thomas JV; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Ludford K; Department of General Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Willis JA; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Higbie VS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Raghav KPS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Johnson B; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Kee BK; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Parseghian CM; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Le PH; Department of General Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Morelli MP; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Bent A; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Vilar E; Clinical Cancer Prevention, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas - MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Dec 11; Vol. 3 (12), pp. 2510-2517.
Autor:
Pellegrini JM; Centre d'Immunologie de Marseille Luminy, INSERM, Centre national de la recherche scientifique (CNRS), Aix-Marseille Université, Parc Scientifique et Technologique de Luminy, Case 906, Marseille, France., Morelli MP; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.; Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina., Colombo MI; Instituto de Histología y Embriología de Mendoza, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo-CONICET, Mendoza, Argentina., García VE; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.; Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Nov 27; Vol. 13, pp. 1332084. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Autor:
Hecht JR; David Geffen School of Medicine at UCLA, Santa Monica, CA., Mitchell J; David Geffen School of Medicine at UCLA, Santa Monica, CA., Morelli MP; UT MD Anderson Cancer Center, Houston, TX., Anandappa G; UT MD Anderson Cancer Center, Houston, TX., Yang JC; National Cancer Institute, Bethesda, MD.
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2023 Jun; Vol. 43, pp. e389072.
Autor:
Cole CB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Morelli MP; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fantini M; Precision Biologics, Inc, Bethesda, MD, USA. massimo.fantini@precision-biologics.com., Miettinen M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fetsch P; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Peer C; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yin T; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Houston N; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McCoy A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lipkowitz S; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zimmer A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pavelova M; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Villanueva EN; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Trewhitt K; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Solarz BB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fergusson M; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mavroukakis SA; Precision Biologics, Inc, Bethesda, MD, USA., Zaki A; Precision Biologics, Inc, Bethesda, MD, USA., Tsang KY; Precision Biologics, Inc, Bethesda, MD, USA., Arlen PM; Precision Biologics, Inc, Bethesda, MD, USA., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. annunzic@mail.nih.gov.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Apr 26; Vol. 42 (1), pp. 102. Date of Electronic Publication: 2023 Apr 26.
Background: Systemic chemotherapy is the mainstay for metastatic Pancreatic Ductal Adenocarcinoma (PDCA). There is a paucity of effective predictive markers of drug sensitivity or resistance in this setting, due in large part to marked difficulties i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::f9f3067e12c3a0f396a572817e055687
https://zenodo.org/record/3647709
https://zenodo.org/record/3647709
Autor:
Tateosian NL; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina.; Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina., Morelli MP; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina.; Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina., Pellegrini JM; Centre d'Immunologie de Marseille Luminy, INSERM, CNRS, Aix-Marseille Université, Parc Scientifique et Technologique de Luminy, Case 906, CEDEX 09, 13288 Marseille, France., García VE; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina.; Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Intendente Güiraldes 2160, Pabellón II, 4°piso, Ciudad Universitaria, Buenos Aires C1428EGA, Argentina.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 06; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 06.
Autor:
Zeineddine FA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zeineddine MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yousef A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gu Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huey RW; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kee B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morelli MP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parseghian C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Raghav K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Willis J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kawaguchi Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Jshen8@mdanderson.org.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2023 Feb 13; Vol. 7 (1), pp. 16. Date of Electronic Publication: 2023 Feb 13.
Autor:
Tsang KY; Precision Biologics, Inc., Bethesda, MD 20814, USA., Fantini M; Precision Biologics, Inc., Bethesda, MD 20814, USA., Zaki A; Precision Biologics, Inc., Bethesda, MD 20814, USA., Mavroukakis SA; Precision Biologics, Inc., Bethesda, MD 20814, USA., Morelli MP; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Annunziata CM; Women's Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Arlen PM; Precision Biologics, Inc., Bethesda, MD 20814, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Oct 12; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 12.